Oxaliplatin-Global Market Status and Trend Report 2015-2026

Table of Contents

Chapter 1 Overview of Oxaliplatin

• 1.1 Definition of Oxaliplatin in This Report
• 1.2 Commercial Types of Oxaliplatin
  • 1.2.1 Mannitol
  • 1.2.2 Glucose Solution
  • 1.2.3 Lactose Solution
  • 1.2.4 Other
• 1.3 Downstream Application of Oxaliplatin
  • 1.3.1 Colorectal Cancer
  • 1.3.2 Stomach Cancer
  • 1.3.3 Ovarian Cancer
  • 1.3.4 Other
• 1.4 Development History of Oxaliplatin
• 1.5 Market Status and Trend of Oxaliplatin 2015-2026
  • 1.5.1 Global Oxaliplatin Market Status and Trend 2015-2026
  • 1.5.2 Regional Oxaliplatin Market Status and Trend 2015-2026

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Oxaliplatin 2015-2019
• 2.2 Production Market of Oxaliplatin by Regions
  • 2.2.1 Production Volume of Oxaliplatin by Regions
  • 2.2.2 Production Value of Oxaliplatin by Regions
• 2.3 Demand Market of Oxaliplatin by Regions
• 2.4 Production and Demand Status of Oxaliplatin by Regions
  • 2.4.1 Production and Demand Status of Oxaliplatin by Regions 2015-2019
  • 2.4.2 Import and Export Status of Oxaliplatin by Regions 2015-2019

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Oxaliplatin by Types
• 3.2 Production Value of Oxaliplatin by Types
• 3.3 Market Forecast of Oxaliplatin by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Oxaliplatin by Downstream Industry
• 4.2 Market Forecast of Oxaliplatin by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Oxaliplatin

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Oxaliplatin Downstream Industry Situation and Trend Overview

Chapter 6 Oxaliplatin Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Oxaliplatin by Major Manufacturers
• 6.2 Production Value of Oxaliplatin by Major Manufacturers
• 6.3 Basic Information of Oxaliplatin by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Oxaliplatin Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Oxaliplatin Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Oxaliplatin Major Manufacturers Introduction and Market Data

• 7.1 Sanofi-Aventis
  • 7.1.1 Company profile
  • 7.1.2 Representative Oxaliplatin Product
  • 7.1.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Sanofi-Aventis
• 7.2 Mylan
  • 7.2.1 Company profile
  • 7.2.2 Representative Oxaliplatin Product
  • 7.2.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Mylan
• 7.3 Sun Pharmaceutical
  • 7.3.1 Company profile
  • 7.3.2 Representative Oxaliplatin Product
  • 7.3.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical
• 7.4 Yakult honsha
  • 7.4.1 Company profile
  • 7.4.2 Representative Oxaliplatin Product
  • 7.4.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Yakult honsha
• 7.5 Hospira
  • 7.5.1 Company profile
  • 7.5.2 Representative Oxaliplatin Product
  • 7.5.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Hospira
• 7.6 Dr Reddy's laboratories
  • 7.6.1 Company profile
  • 7.6.2 Representative Oxaliplatin Product
  • 7.6.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Dr Reddy's laboratories
• 7.7 Nanjing Pharmaceutical Factory
  • 7.7.1 Company profile
  • 7.7.2 Representative Oxaliplatin Product
  • 7.7.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Nanjing Pharmaceutical Factory
• 7.8 Fresenius Kabi
  • 7.8.1 Company profile
  • 7.8.2 Representative Oxaliplatin Product
  • 7.8.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Fresenius Kabi
• 7.9 Teva
  • 7.9.1 Company profile
  • 7.9.2 Representative Oxaliplatin Product
  • 7.9.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Teva
• 7.10 Jiangsu Hengrui Medicine
  • 7.10.1 Company profile
  • 7.10.2 Representative Oxaliplatin Product
  • 7.10.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Jiangsu Hengrui Medicine
• 7.11 Luoxin
  • 7.11.1 Company profile
  • 7.11.2 Representative Oxaliplatin Product
  • 7.11.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Luoxin
• 7.12 Hainan Jinrui Pharmaceutical
  • 7.12.1 Company profile
  • 7.12.2 Representative Oxaliplatin Product
  • 7.12.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Hainan Jinrui Pharmaceutical
• 7.13 Jiangsu Aosaikang Pharmaceutical
  • 7.13.1 Company profile
  • 7.13.2 Representative Oxaliplatin Product
  • 7.13.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Jiangsu Aosaikang Pharmaceutical
• 7.14 Chiatai Tianqing
  • 7.14.1 Company profile
  • 7.14.2 Representative Oxaliplatin Product
  • 7.14.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Chiatai Tianqing
• 7.15 Halfsky Pharmacy
  • 7.15.1 Company profile
  • 7.15.2 Representative Oxaliplatin Product
  • 7.15.3 Oxaliplatin Sales, Revenue, Price and Gross Margin of Halfsky Pharmacy
• 7.16 Lunan Pharmaceutical
• 7.17 Qilu Pharmaceutical
• 7.18 Jari Pharmaceutical
• 7.19 YRPG
• 7.20 Hisun Pharmaceutical

Chapter 8 Upstream and Downstream Market Analysis of Oxaliplatin

• 8.1 Industry Chain of Oxaliplatin
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Oxaliplatin

• 9.1 Cost Structure Analysis of Oxaliplatin
• 9.2 Raw Materials Cost Analysis of Oxaliplatin
• 9.3 Labor Cost Analysis of Oxaliplatin
• 9.4 Manufacturing Expenses Analysis of Oxaliplatin

Chapter 10 Marketing Status Analysis of Oxaliplatin

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources